Mentice Expands its Coronary Product Portfolio with an Advanced Software Solution for Coronary Interventions
Coronary Advanced to Help Fellows and Attending Interventional Cardiologists to Perfect Skills in...
30–40% average annual revenue growth during short to medium term (next 3-5 years).
30 % EBITDA margin within short to medium term (3-5 years).
Mentice is a company on a rapidly growing market. In order to capitalize on its market opportunities, the company will prioritize growth, both organic and through acquisitions.